Submissions from 2021
Recognizing and treating HFpEF: the biggest pulmonary arterial hypertension imitator!, Sophia Airhart
Tips and tricks for invasive assessment of aortic stenosis, Tamara Atkinson, Jayant Bagai, and Crispin Davies
Experience in a blood conservation initiative in cardiac surgery, James Brevig, Ruyun Jin, and Matthew Ducsik
Cardiovascular care in unusual places—delivering value beyond bricks and mortar, Tyler J Gluckman
Cardiovascular involvement in COVID-19: The good, the bad, and the unknown, Tyler J Gluckman
Clinical care in a post-pandemic world: what we learned and where we go from here, Tyler J Gluckman
COVID-19’s impact on common cardiovascular quality metrics, Tyler J Gluckman
Evolving treatment approaches for hypertrophic cardiomyopathy, Tyler J Gluckman
How will selected 2021 ACC clinical trial findings change our practice?, Tyler J Gluckman
Optimal LDL-cholesterol: Individualizing treatment using statins and nonstatin therapy, Tyler J Gluckman
Peer-to-peer quality programs that actually work, Tyler J Gluckman
Quality of care, appropriate use criteria, the ACC-NCDR Registry and professional code of ethics, Tyler J Gluckman
Same day discharge- what opportunities exist and why should I be doing it?, Tyler J Gluckman
Same day discharge- what opportunities exist and why should I be doing it?, Tyler J Gluckman
What did we learn from COVID-19?, Tyler J Gluckman
Evolving Treatment Approaches for Hypertrophic Cardiomyopathy: Essential Updates for Specialty Pharmacy, Tyler J Gluckman, Martin S. Maron, Ryan J. Atkinson, Donna M. Chiefari, Judith R. Sands, and Henry A. Solomon
Impact of Age on Outcomes in Patients With Cardiogenic Shock., Manreet Kanwar, Katherine L Thayer, Arthur Reshad Garan, Jaime Hernandez-Montfort, Evan Whitehead, Claudius Mahr, Shashank S Sinha, Esther Vorovich, Neil M Harwani, Elric Zweck, Jacob Abraham, Daniel Burkhoff, and Navin K Kapur
Alternative access: Transcarotid, Ethan C Korngold
Cardiovascular risk assessment and disease management in patients with cancer, Michael Layoun
Hyperbaric oxygen therapy: monoplace chamber, A Perez
Cardiac disease and vascular imaging, Alejandro Perez
Coding changes for wound care clinician-2021 updates, Alejandro Perez
Demographics and cost of venous leg ulcers, Alejandro Perez
Efforts and progress on key vascular quality measures, Alejandro Perez
Hyperbaric oxygen therapy: treatment indications, Alejandro Perez
Peripheral arterial disease: diagnosis and medical management, Alejandro Perez
Peripheral artery disease: basic principles for the wound care clinician, Alejandro Perez
Scanning below the knee arteries- how to determine stenosis when there no validated criteria?, Alejandro Perez
Wound care local coverage determination, Alejandro Perez
Heart to heart: cardiology and nephrology discuss heart failure management, A Ross and C Kassakian
Strategic interventional approach to femoropopliteal occlusive disease, Brant Ullery
Submissions from 2020
Dangerous liaisons in pulmonary hypertension, Sophia Airhart
ACCEL Lite: Case Rates, Treatment, and Outcomes in AMI During the COVID-19 Pandemic, Alison Bailey, Joseph Edward Marine, Tyler J Gluckman, and Yuvraj Chowdhury
Analysis of changes in decision-making process during optical coherence tomography-guided percutaneous coronary interventions: insights from the LightLab initiative, Hiram Bezerra, Luis Dallan, Gabriel Tensol, Jana Buccola, Jason R Wollmuth, John Lopez, Richard Rapoza, Nick West, Brian Bergmark, and Kevin Croce
COVID-19 and the CV service line: practical approaches for an unprecedented pandemic—Part 1, Jerry Blackwell, Cathie Biga, Geoffrey Rose, Tyler J Gluckman, John Rebok, and Eugene Yang
Digital service in a virtual era: connecting the dots to help your community and save the world without leaving your home, Andrew Burgie, Liam Elkind, Alison Grady, and Xiaoyan Huang
Building and implementing team-based care in a successful financial model, Tyler J Gluckman
Cardiovascular issues related to COVID-19, Tyler J Gluckman
Coming to grips with chronic heart failure - keeping up with best practices, Tyler J Gluckman
COVID-19’s Impact on Non-Communicable Diseases – The Enormous Toll it Has Taken, Tyler J Gluckman
COVID-19 Web Series Part 10: Cardiovascular Issues Related to COVID-19, Tyler J Gluckman
Cross-industry real-world evidence (RWE), Tyler J Gluckman
First do no harm—approaches to PPE and testing, Tyler J Gluckman
Intersection of antiplatelets and anticoagulants—What to do when a patient needs both?, Tyler J Gluckman
Late-breaking clinical trials III, Tyler J Gluckman
Leveraging technology for quality improvement—what would Alexa and Siri say?, Tyler J Gluckman
New Payment Model for E/M Services: Benefits and Risks of One Level of Service, Tyler J Gluckman
Non-communicable Diseases and the Toll it has Taken, Tyler J Gluckman
Quality of care, appropriate utilization criteria, the ACC-NCDR and professional code of ethics, Tyler J Gluckman
Remote Patient Monitoring to Help with Cardiovascular Prevention During the COVID-19 Pandemic, Tyler J Gluckman
We have a service line: now what?, Tyler J Gluckman
We started. Now we need to implement (and get paid for) these subspecialty clinics, Tyler J Gluckman
Managing Chronic Disease During COVID-19: Views From the US and Europe, Tyler J Gluckman, Katie Berlacher, and Simon G. Ray
Race, Ethnicity, & Social Determinants in COVID-19: An Expert Panel Discussion, Tyler J Gluckman, Clyde W. Yancy, and Shrilla Banerjee
Practicing Cardiology in Portland 2020: Amidst Covid, Protests and Fire, Xiaoyan Huang
Intravascular Lithotripsy for Peripheral Artery Disease and Vascular Access, Ethan C Korngold
Strategies for Aorto-Iliac CTO Crossing, Ethan C Korngold
Transcarotid TAVR: The best alternative, Ethan C Korngold
The Impact of Local Heart Allocation on Post-Transplant Survival, Vidang P. Nguyen and T Dardas
Advanced symposium peripheral arterial disease: controversies in treatment, Alejandro Perez
Hyperbaric medicine hyperbaric oxygen therapy: monoplace chamber, Alejandro Perez
Peripheral artery disease: basic principles for the wound care clinician, Alejandro Perez
Updates in Venous Disease Management, Alejandro Perez
Vascular testing, know why provider wants testing, Alejandro Perez
Device selection in TEVAR, Brant Ullery
Grand Rounds: Spinal protection strategies in contemporary aortic surgery, Brant Ullery
Management of abdominal aortic aneurysms with hostile infrarenal necks, Brant Ullery
Nearly 30 years of EVAR: Contemporary insights on long-term durability, Brant Ullery
Peripheral artery disease: Patient treatment, selection and device options in vascular surgery, Brant Ullery
Practical tools as healthcare emerges from the pandemic, Brant Ullery
Role of TEVAR in acute aortic syndromes, Brant Ullery
Supporting ruptured abdominal aortic aneurysm cases, Brant Ullery
Technical challenges in the treatment of ruptured AAAs. How to salvage the opportunity for ruptured EVAR, Brant Ullery
TEVAR in the fragile aorta, Brant Ullery
Embolization: thrombus, air, other, Jason R Wollmuth
Faculty panel - Intelligent intervention. Complex case examples incorporating lessons from SYNTAX 2, Jason R Wollmuth
High risk PCI program implementation and protocol development, Jason R Wollmuth
Live case panelist, case 3 & 4, Jason R Wollmuth
Live case panelist, case 5 & 6, Jason R Wollmuth
New Advances in Avoiding Complications - Single Site Access in Impella-Assisted CTO PCI, Jason R Wollmuth
Retrograde CTO PCI, Jason R Wollmuth
Revascularization, support, and unloading: past, present, and future directions – protect IV: the synergy of MCS and complete revascularization, Jason R Wollmuth
Side branch access, Jason R Wollmuth
Single access Impella, Jason R Wollmuth
Treating LV dysfunction – impact of complete revascularization on improvement in EF and heart failure, Jason R Wollmuth
Treating LV dysfunction – impact of complete revascularization on improvement in EF and heart failure, Jason R Wollmuth
Understanding how the use of routine oct workflow changes physician decisions: LightLab insights, Jason R Wollmuth
COVID-19 lessons learned from China: disease management, clinical research and health policy, Wenhong Zhang, Sten H. Vermund, Xiaoyan Huang, and Kevin Ye
Submissions from 2019
High Tech, Meet High Touch, James G Beckerman
50 Years of Heart Valve Replacement: Effect of Prosthesis Choice on Long-Term Outcomes, Anthony P Furnary
Pharmacologic therapies to improve HF outcomes, Jill M Gelow
A case study on many views on value: Aortic valve replacement, Tyler J Gluckman
Advances in Heart Failure Management: How Will Recent Guideline Change Impact Your Treatment Selections, Tyler J Gluckman
Advances in heart failure management: How will recent guideline changes impact your treatment selections?, Tyler J Gluckman
Beyond the New Hypertension Guidelines: Understanding and Implementing in Current Practice - Executive Summary What Has Changed?, Tyler J Gluckman
Beyond the New Hypertension Guidelines: Understanding and Implementing in Current Practice - We Should Have Left it Alone: JNC7 Was Just Fine, Tyler J Gluckman
Closing the stroke prevention gap in nonvalvular atrial fibrillation—Real world data and its impact on patient outcomes., Tyler J Gluckman
How Can ACCorg Help You Implement Cholesterol Guidelines in Your Practice, Tyler J Gluckman
